Oral Solid Dosage

Less than 1 min 06/05/21
Author name: John Ross

Q&A with Metrics and Recipharm: The latest oral solid dosage challenges

In this article with European Pharmaceutical Manufacturer, John Ross, President of Metrics Contract Services and Mayne Pharma US, discusses the latest challenges and trends in oral solid dose manufacturing. “As the number of poorly soluble and poorly bioavailable APIs in development continues to rise, so too do the challenges for formulation scientists trying to develop pharmaceutical dosage forms. It is these qualities that contribute to poor attrition rates of drugs in development, which translates into longer development times to formulate new products and delays in getting them to market.” Read the full article here.


Related Content